Testimonials

Background stories of how others approached and experienced their European Horizon funding trajectory.

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Published on | 6 months ago

Programmes Health

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article for details 
Other available testimonials

Testimonial

image of BENEDMO - Flemish-Dutch collaboration against disinformation

BENEDMO - Flemish-Dutch collaboration against disinformation

Textgain is a Flemish SME and a partner in Digital Europe project BENEDMO, which answered to call ‘European Digital Media observatory (EDMO) - National and multinational hubs’.

Its task within the project is to further develop technologies to effectively detect sources of polarisation and disinformation, allowing journalists and moderators to quickly mitigate the harmful effects of such messages.